Establishment and clinical performance evaluation of the thyroglobulin colloidal gold immunochromatographic assay - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Development and Clinical Assessment of a Colloidal Gold Immunochromatographic Assay for Thyroglobulin Detection

  • By

  • Qi Yang

  • Jifeng Li

  • Jinzi Hui

  • Jia Dai

  • Hongbian Gao

  • Yuan An

  • August 17, 2026

Share

Clinical Report: Development and Clinical Assessment of a Colloidal Gold Immunochromatographic Assay for Thyroglobulin Detection

Overview

This study evaluates a new colloidal gold immunochromatographic assay (CGICA) for detecting thyroglobulin in patients with differentiated thyroid carcinoma (DTC). The CGICA method demonstrated comparable performance to traditional methods.

Background

The incidence of differentiated thyroid carcinoma (DTC) has been rising, with lymph node metastasis significantly increasing the risk of recurrence and mortality. Accurate detection of lymph node involvement is crucial for surgical planning and patient outcomes. Current methods, while effective, often require advanced equipment and can delay diagnosis.

Data Highlights

MethodCutoff ValueSensitivity
CGICA22.05 μg/L90%
Roche ECLIA233.25 μg/L86.25%

Key Findings

  • The CGICA method showed a correlation coefficient of r=0.996 with the Roche ECLIA method.
  • CGICA demonstrated greater sensitivity for lymph node specimens compared to Roche ECLIA.
  • Diagnostic accuracy of CGICA was comparable to intraoperative frozen section histopathology.
  • CGICA allows for rapid quantification of thyroglobulin via fine-needle aspiration biopsies.
  • The study included 185 serum samples and 120 lymph node samples from patients undergoing surgery.

Clinical Implications

The CGICA method provides a rapid alternative for detecting thyroglobulin.

Conclusion

The CGICA method represents an advancement in the detection of thyroglobulin in thyroid cancer patients.

Related Resources & Content

  1. The Journal of Clinical Endocrinology & Metabolism, 2025 -- A Prospective, Blinded Investigation of Thyrotropin Receptor Antibodies in Autoimmune Thyroid Disorders Conducted in the United States
  2. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Thyroglobulin Thresholds for Monitoring Low- and Intermediate-risk Thyroid Cancer: Insights from ITCO Real-world Data Analysis
  3. Frontiers in Endocrinology, 2025 -- Behavior of serum thyroglobulin in relation to thyroid function under low-thyrotropin conditions in general practice
  4. Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
  5. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
  6. Archives of Toxicology — Enhanced Techniques for Assessing Competitive Binding of Chemical Agents to Thyroid Hormone Transport Proteins Transthyretin and Thyroxine-Binding Globulin
  7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  8. Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
  9. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
  10. oup.silverchair-cdn.com
  11. Study on the Application Value of Colloidal Gold Immunochromatography Assay Combined With Fine Needle Aspiration Biopsy for Identifying Lymph Node Metastasis in Papillary Thyroid Carcinoma - Mao - 2025 - Diagnostic Cytopathology - Wiley Online Library

Original Source(s)

Related Content